These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20644201)

  • 1. The increasing epidemiology of diabetes and review of current treatment algorithms.
    Freeman JS
    J Am Osteopath Assoc; 2010 Jul; 110(7 Suppl 7):eS2-6. PubMed ID: 20644201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating treatment algorithms for the management of patients with type 2 diabetes mellitus: a perspective on the definition of treatment success.
    Aguilar RB
    Clin Ther; 2011 Apr; 33(4):408-24. PubMed ID: 21635988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks and benefits of attaining HbA(1c) goals: examining the evidence.
    Shubrook JH
    J Am Osteopath Assoc; 2010 Jul; 110(7 Suppl 7):eS7-12. PubMed ID: 20644204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing current diagnostic criteria and treatment algorithms for managing type 2 diabetes mellitus.
    Kruger DF; Boucher JL; Banerji MA
    Postgrad Med; 2011 Jul; 123(4):54-62. PubMed ID: 21680989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving glycemic control and cardiometabolic risk through integrated treatment plans.
    Lavernia F
    J Am Osteopath Assoc; 2010 Jul; 110(7 Suppl 7):eS13-9. PubMed ID: 20644200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes mellitus in children and youth.
    Ramkumar S; Tandon N
    Indian J Pediatr; 2013 Mar; 80 Suppl 1():S87-94. PubMed ID: 23430571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm.
    Bailey T
    Am J Med; 2013 Sep; 126(9 Suppl 1):S10-20. PubMed ID: 23953074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reaching HbA1c goals with saxagliptin in combination with other oral antidiabetic drugs.
    LaSalle JR
    Postgrad Med; 2010 Jan; 122(1):144-52. PubMed ID: 20107298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of type 2 diabetes: new or previous agents, how to choose?].
    Halimi S
    Presse Med; 2013 May; 42(5):861-70. PubMed ID: 23643613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining clinical judgment with guidelines for the management of type 2 diabetes: overall standards of comprehensive care.
    Yacoub TG
    Postgrad Med; 2014 May; 126(3):85-94. PubMed ID: 24918794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Screening and Prevention of Diabetes Mellitus.
    Martinez LC; Sherling D; Holley A
    Prim Care; 2019 Mar; 46(1):41-52. PubMed ID: 30704659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.
    Tao T; Wu P; Wang Y; Liu W
    BMC Endocr Disord; 2018 Feb; 18(1):14. PubMed ID: 29482528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.
    Thompson AM; Linnebur SA; Vande Griend JP; Saseen JJ
    Consult Pharm; 2014 Feb; 29(2):110-23. PubMed ID: 24513421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
    Tasci I; Safer U; Naharci I; Sonmez A
    Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slow response to loss of glycemic control in type 2 diabetes mellitus.
    Brown JB; Nichols GA
    Am J Manag Care; 2003 Mar; 9(3):213-7. PubMed ID: 12643338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distance to glycemic goal at the time of treatment intensification in patients with type 2 diabetes mellitus failing metformin monotherapy in the United States.
    Fernandes G; Sawhney B; Hannachi H; Liu J; Wang T; Fu AZ; Iglay K; McNeill A; Rajpathak S
    Curr Med Res Opin; 2020 May; 36(5):741-748. PubMed ID: 31990206
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of the therapeutic uses of liraglutide.
    Ryan GJ; Foster KT; Jobe LJ
    Clin Ther; 2011 Jul; 33(7):793-811. PubMed ID: 21741090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.
    Nadeau DA
    Postgrad Med; 2013 May; 125(3):112-26. PubMed ID: 23748512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
    Rodbard HW; Jellinger PS; Davidson JA; Einhorn D; Garber AJ; Grunberger G; Handelsman Y; Horton ES; Lebovitz H; Levy P; Moghissi ES; Schwartz SS
    Endocr Pract; 2009; 15(6):540-59. PubMed ID: 19858063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women with Type 2 Diabetes and Glycemic Control.
    Gosse S
    Medsurg Nurs; 2014; 23(5):317-20, 329. PubMed ID: 26292437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.